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ABSTRACT

The purpose of this project was to investigate the role of the Checkpoint
Suppressor 1 (Ches1) gene in mammalian development. The Ches1 gene
belongs to the fork head transcription factor family and has been implicated in
controlling the G2-M phase of the cell cycle in lower eukaryotes. Furthermore,
Ches1 has been shown to bind the Sin3/Rpd3 HDAC complex in an inhibitory
manner in yeast. In human tumor cell lines, Ches 1 appears to negatively
regulate gene expression through the recruitment of SKIP. While the functional
role of Ches1 (Foxn3) in higher mammalian models is not well understood, it is
under-expressed in both renal cell and oral squamous cell carcinomas.
Our initial analysis indicates that we have generated Ches 1 mutant mice,
and we plan to characterize the mutant mice for phenotypes that relate to
developmental disorders as well as cancer formation. Our preliminary data
suggests that loss of Ches1 results in embryonic lethality in mice. Our studies on
the expression pattern of Ches1 in 11.5 days post coitum embryos show marked
expression of Ches1 throughout the spinal cord. Observations of our Ches1
mutant colony have resulted in the phenotypic characterization of distinct skeletal
abnormalities in Ches1 heterozygotes. Future experiments will test our
deduction of embryonic lethality, will further characterize Ches1 expression in
embryonic development, and will address cancer susceptibility.
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THE CELL CYCLE

The cell cycle consists of four phases with the ultimate goal of replicating
the genetic information encoded on the DNA and then segregating it equally into
two daughter cells. The four phases are gap 1 (G1), synthesis (S), gap 2 (G2),
and mitosis (M).
Cells enter G1 after completion of a previous cycle. During this phase of
variable length, the cell grows and proceeds through its normal metabolic
functions. The cell subsequently proceeds to S phase, in which the DNA is
replicated. Each chromosome replicates semi-conservatively to form two
identical sister chromatids. After replication, sister chromatids remain attached to
one another at the centromere via cohesin protein complexes. The kinetochore,
a trilaminar structure composed of many proteins, is also formed at the
centromere and functions to link the chromatids to spindle fibers later during
mitosis. After S phase, the cell proceeds to G2, in which cell growth occurs in
anticipation of division.
Mitosis, or cell division, generates two daughter nuclei that are identical to
the parent nucleus. Mitosis is divided into five continuous stages: prophase,
prometaphase, metaphase, anaphase, and telophase. During prophase, the
chromosomes condense, the two centrosomes move to opposite poles of the
cell, and the mitotic spindle is formed as microtubules are synthesized from each
centrosome. Prometaphase begins as the nuclear envelope disintegrates, which
allows microtubules of the spindle to attach to the kinetochore of each chromatid.
Each sister chromatid of one chromosome must attach to opposite poles for
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proper orientation. During metaphase, the chromosomes become aligned at a
midpoint known as the metapl1ase plate of the cell. After proper alignment and
kinetochore attachment is achieved, anaphase occurs. During anaphase, the
sister chromatids separate and move toward opposite poles of the cell. In
telophase, nuclear envelopes reform around each of the two clusters of daughter
chromosomes. Finally, cell division is completed by cytokinesis, the process that
divides the cytoplasm into two distinct daughter cells, each containing a nucleus
with identical chromosomes.
Coordination of the stages and intricate processes in the cell cycle is
driven by kinase complexes. The active form of these complexes consists of at
least two proteins, the catalytic subunit known as a cyclin-dependent-kinase
(CDK) and the regulatory subunit known as a cyclin (Hartwell and Kastan, 1994).
These complexes undergo changes in the CDK and cyclin subunits that drive the
cycle 'from one stage to another. In Saccharomyces cerevisiae, a single kinase,
CDC28, interacts successively with a series of transiently expressed cyclins
(Nasmyth, 1993). Each cyclin has a periodic spike in expression to drive a phase
of the cell cycle, and the cyclin protein is rapidly degraded after translation
(Molinari, 2000). The situation in mammalian cells is considerably more
complicated as multiple CDK's and cyclins function to regulate cell cycle
progression; however, the overall theme remains the same.

Starnes 4

CELL CYCLE CHECKPOINTS
Cell cycle checkpoints are mechanisms that ensure the order of events in
the cell cycle and that integrate DNA repair with cell cycle progression (Hartwell
and Kastan, 1994). These checkpoints make sure that progression to the next
event occurs only after completion of a prior event in the cell cycle. If certain
conditions have not been met or if DNA damage is present, the cycle will arrest
at these checkpoints.
There are four major areas of cell cycle control: the G1/S checkpoint, the
intra-S phase checkpoint, the G2/M checkpoint, and the spindle checkpoint
before anaphase in mitosis (Molinari, 2000). The G1/S checkpoint prevents the
cell from replicating its DNA if any damage is present (Hartwell and Kastan,
1994). In mammalian cells in G1, the dominant checkpoint response to DNA
damage is the ATM(ATR}/CHK2(CHK1}-p53/MDM2-p21 pathway, which is
capable of inducing sustained G1 arrest (Kastan and Lim, 2000). An arrest of the
cell cycle may allow time for DNA repair or may commit a damaged cell to
apoptosis (Weinert, 1998).
The intra-S phase checkpoint is activated by genotoxic stress in the cell
during replication. In the presence of such stress, the firing of origins of
replication is inhibited in order to slow DNA synthesis (Kastan and Bartek, 2004).
There are two parallel pathways to this checkpoint, both of which are controlled
through ATM/ATR signaling (Kastan and Bartek, 2004).
The G2/M checkpoint prevents progression into mitosis in the presence of
either DNA damage or incompletely replicated DNA (Hartwell and Kastan, 1994).
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In S. eerevisiae, the RAD9, RAD17, RAD24, MEC1 (a functional homologue of
the human ATM gene), MEC2, and MEC3 gene products block mitosis in the
presence of DNA damage or if replication is blocked in late S phase; MEC1 and
MEC2 also prevent mitosis if replication is blocked in early S phase (Hartwell and
Kastan, 1994). This pathway is not yet well understood in mammals.
The spindle checkpoint ensures the integrity of segregation of sister
chromatids in mitosis. This checkpoint prevents the onset of anaphase until the
following prerequisites are achieved: assembly of a bipolar spindle, attachment of
kinetochores of sister chromatids to spindle fibers emanating from opposite
poles, and arrival of the attached chromosomes at the metaphase plate (Elledge,
1996). While many of the details of this pathway are not yet understood, it is
thought that a lack of tension at the kinetochore and/or an unattached
kinetochore activates the checkpoint response (Amon, 1999).

CHECKPOINT SUPPRESSOR 1
CHES1 (Checkpoint suppressor 1; FOXN3) , a novel human cDNA, was

first isolated as a high-copy suppressor of the S. eerevisiae G2/M checkpoint
mutants rad9, mee1, rad24, rad53, and dun 1 (Pati et aI., 1997). CHES1 encodes
a 490 amino acid member of the forkhead/winged helix family and has been
mapped to a region between 14q24.3 and 14q31 (Pati et aI., 1997).
The forkhead family is a large family of transcription factors that share a
structurally related DNA binding domain: the forkhead. This domain is
approximately 110 amino acids long, and it folds into a structure with three alpha
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helices and three beta strands, which assemble into a compact hydrophobic core
(Granadino et aI., 2000). Members of this family have been found in a wide
range of species, with the exception of green plants (Granadino et aI., 2000).
Forkhead proteins bind DNA as monomers and regulate transcription
independently, either as activators or repressors . In some cases , however, they
can also serve as transcriptionally inert docking factors for other proteins with
transcriptional regulatory domains (Granadino et aI. , 2000).

CHES1 belongs to the FOXN subfamily of forkhead transcription factors.
This subfamily contains five members in addition to CHES1: FOXN1 (WHN) , a
regulator of keratinocyte growth and differentiation of thymic epithelium (Coffer
and Burgering, 2004); FOXN2 (human T-cell leukemia virus enhancer factor),
which binds to the human T-cell virus long terminal repeat and may be involved
in transcriptional regulation (Li et aI., 1992); and FOXN4-6, which have only
recently been identified (Katoh and Katoh , 2004a-c).

3'
3' UTR

(Llkb)

eHES 1 (2.4kb)
Figure 1. Schematic diagram of the full-length CHES1 cDNA (Pati et al., 1997)

The CHES1 clone first isolated by the work of Pati et al. only encoded the
carboxy terminus of the full protein , which lacks the forkhead DNA binding
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domain (Fig. 1). This truncated cDNA conferred increased survival of the
aforementioned G2/M checkpoint mutants after exposure to UV irradiation,
ionizing irradiation, and methyl methane sulfonate (MMS) (Pati et aI., 1997).
Furthermore, this suppression was accompanied by a reconstitution of a wildtype G2 arrest after DNA damage in spite of mutations in essential checkpoint
genes (Pati et aI., 1997). CHES1 was also able to suppress the null alleles of
MEC1--which has been described as being essential for growth in the absence of
DNA damage (Kato and Ogawa, 1994)-RA09, and OUN1 (Pati et al., 1997).
Because the forkhead domain was not included in the truncated CHES1 clone
used in these experiments, it does not appear that Ches1 induces new genes for
restoration of the checkpoint. Pati et al. proposed that Ches 1 may activate an
alternative MEC1-independent pathway which results in G2 arrest after damage
(Fig. 2).

irof'1$Cripnonoi
~nductioli

Figure 2. Possible mechanism of Ches1 action in cell cycle control (Pati et aI., 1997)

In a study aimed at further elucidating information on the Ches1
mechanism in yeast, the C-terminus of Ches1 was fused to glutathione

s

transferase (GST) in order to identify S. cerevisiae proteins that interact with the
Ches1 in vivo (Scott and Pion, 2003). It was found that the Ches1 fusion protein
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interacts with Sin3, a component of the Sin3/Rpd3 histone deacetylase complex
(HDAC) in budding yeast (Scott and Pion, 2003). Rather than binding directly to
DNA, the Sin3/Rpd3 HDAC complex is targeted to specific promoter regions via
Sin3 interactions with site-specific DNA-binding proteins (Kadosh and Struhl,
1997).
The HDAC complex is a type of chromatin remodeling complex that
removes acetyl groups on lysine residues of the amino-terminal ends of histones,
particularly histones H3 and H4. The modulation of chromatin is a major route of
gene regulation. Specifically, acetyl groups post-translationally added to these
lysine residues neutralize the positive charge of the amino acid, which diminishes
the electrostatic interaction of the histone with the negatively-charged DNA,
thereby loosening chromatin structure (Neely and Workman, 2002). This
loosening of chromatin structure by acetylation makes the DNA more accessible
to transcriptional machinery for gene expression. Therefore, deacetylation via
HDACs accomplishes the opposite: it restores the positive charge of the lysine
residue to allow a stronger and tighter interaction between histone and DNA,
effectively repressing transcription.
In the study of Ches1 and Sin3 interaction, Ches1 did not suppress the
DNA damage response in sin3 mutants, and over-expression of SIN3 blocked
the Ches1-mediated G2 arrest after DNA damage (Scott and Plan, 2003). This
evidence implies that the Ches 1 mechanism in suppressing S. cerevisiae
checkpoint mutants and in restoring G2 arrest functions through the inhibition of
Sin3/Rpd3 HDAC activity. By inhibiting this complex, target lysine residues
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would remain acetylated and target gene expression would continue. This
conclusion is consistent with prior work, which demonstrated that acetylation of
H3 and H4 histone tails is necessary for the cell cycle transition of G2 to M phase
in the absence of DNA damage (Howe et aI., 2001). Further investigation into
the mechanism of DNA damage-induced arrest in both sin3 and rpd3 mutants
revealed the dependency of the reconstituted G2/M arrest on the MAD1
dependent spindle checkpoint pathway (Scott and Pion, 2003).
Scott and Pion published a second study in 2005 on Ches 1 function in
human cells. In this study, the C-terminus of Ches1 was shown to consistently
repress transcription when targeted to a reporter promoter in cell lines derived
from tumor tissues. Through screening of a cDNA library derived from fetal brain
tissue and subsequent co-immunoprecipitation assays, Ches 1 was found to
interact with SKIP (Ski -interacting protein) (Scott and Pion, 2005). SKIP is a
well-conserved transcriptional adaptor protein that functions to recruit either
activation or repression complexes to mediate multiple signaling pathways
involved in the control of cell proliferation and differentiation (Dahl et aI., 1998).
Specifically, Ches1 directly interacts with the hydrophobic C-terminus of SKIP (aa
470-536), which defines a new region of SKIP protein-protein interaction (Scott
and Pion, 2005). The findings in this study imply that Ches1 negatively regulates
transcription through recruitment of SKIP. SKIP has been shown to bind the
following repression complex members: mSin3a, HDAC1, and HDAC2 (Laduron
et aI., 2004). This data is consistent with the finding that Ches1 inhibits the yeast
orthologs of these proteins (Scott and Pion, 2003).
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CHES1 AND CANCER
In light of Ches1's involvement in suppressing checkpoint mutant
phenotypes and in restoring G2 arrest after DNA damage in S. cerevisiae, we
hypothesize that loss of Ches1 function will lead to higher cancer incidence in
mammalian cells. The G2/M checkpoint functions to arrest the cell cycle in the
presence of DNA damage or unreplicated DNA before entering mitosis. Loss of
this control could allow a cell to enter mitosis with damage and pass its mutations
on to its daughter cell(s). Incorporation of mutations can lead to loss of protein
function and genetic instability, each of which make the cell more susceptible to
further damage. Mutations of cell cycle checkpoint genes increase genetic
instability and accelerate the process of cellular evolution toward the loss of cell
cycle control, the hallmark of cancer (Hartwell and Kastan, 1994).
Recent studies have shown CHES1 to be under-expressed in multiple
tumor types. Struckmann et al. reported a 60% CHES1 expression frequency in
normal renal tissue with only a 14% expression frequency in clear cell renal cell
carcinomas (cRCC). CHES1 was also under-expressed in samples of oral
squamous cell carcinoma (OSCC) as compared to normal tissues (Chang et aI.,
2005). Specifically, it was under-expressed in 46% of tumor samples studied,
and, on average, its expression was decreased by 15.03-fold in OSCC cells
(Chang et aI., 2005). Chang et al. also noted a correlation between the under
expression of CHES1 and the expression of CDK1 in oral cancer samples, which
they interpreted as an indication of a relationship between the regulatory
mechanisms of the two genes. The down-regulation of CHES1 in malignant
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tissues along with the finding that Ches1 recruits SKIP to repress transcription
indicate that genes regulated by Ches1 may be over-expressed in cancerous
cells due to decreased Ches1 levels (Scott and Pion, 2005).

RESULTS AND METHODS
Generation of Ches 1 Mouse Models
In order to study the effects of a loss-of-function mutation of CHES1 in
mammals, Ches1 deficient mice were generated by the following means. Murine
embryonic stem (ES) cells with a gene-trap inserted into the Ches1 gene were
obtained from the Mutant Mouse Regional Resource Center (MMRRC, UC
Davis). A schematic of the Ches1 gene in Mus musculus is shown in Figure 3
and a schematic of the gene-trap insertion is shown in Figure 4. The gene-trap
has a strong splice acceptor site that disrupts the normal splicing of CHES1
mRNA, which results in a non-functional, truncated Ches1 protein. The location
of the trap was found to be downstream of exon 2 according to the automated 5'
RACE annotation provided by tl1e MMRRC.
These embryonic stem cells were used for blastocyst injections, and the
resulting embryos were implanted into pseudo-pregnant females. The result of
these transgenic embryos was the generation of chimeric mice. A chimera has
some cells derived from the host's ES cells while other cells are derived from the
transgenic ES cells (129 Ola/Hsd background), which in this case are the cells
with Ches1 mutated. The chimeras were mated to c57/BL6 wild type female
mice to ascertain whether the Ches1 mutant cells contributed to the germ line of
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the chimeras. If they had, some of the resulting offspring would be heterozygous
for Ches1 and would have an agouti coat color. Offspring of the chimera and
wild type crosses were genotyped using peR (polymerase chain reaction)
analysis, and heterozygous mice were bred to expand the colony.

I

I

I

I I

I

Figure 3. Ches1 Gene in Mus musculus. Exons 1-6 shown from left to right as black rectangles.

Gene-trap primer
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Figure 4. Schematic representation of the gene-trap disruption of Ches1.
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PCR Analyses and Genotyping

Despite the 5'RACE confirmation of the location of the gene-trap provided
by the Mutant Mouse Regional Resource Center, PCR analysis utilizing gene
specific primers and trap specific primers have failed. We designed primers
specific for intron 2 and the gene-trap to amplify a Ches1-gene-trap product that
is expected in the heterozygous offspring. Analysis with at least a dozen
different primer pairs spanning the whole of intron 2 did not provide any mutant
specific PCR product. If the trap is inserted into the 46 kb-Iong intron 2, this
problem may be due to the enormous size of the intron and/or the redundancy of
intron sequences within the mouse genome. Furthermore, our experiments are
based on a mouse genome database that is not completely curated.
Consequently, our efforts in genotyping offspring of the founder mice have
been limited to PCR amplification of gene-trap sequences using two gene-trap
primers. While this analysis enables us to confirm the presence of the gene-trap
within a mouse's genome, it does not enable confirmation of the location of the
gene-trap within the Ches1 gene. Furthermore, gene-trap specific PCR analysis
does not enable differentiation between Ches1 heterozygous and nullizygous
mice.

5'RACE: Rapid Amplification of cDNA Ends

Due to unsuccessful efforts to design a PCR that will amplify a Ches1
gene-trap product and due to a 1% chance of clonal contamination, we employed
5'RACE ( 5' Rapid 8mplification of ~DNA 1;nds) to confirm the presence of the
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gene-trap in the Ches1 gene (Figure 5). Total RNA was isolated from the spleen
of a Ches1 heterozygous mouse using TRlzOL reagent (Invitrogen).

mRNA
5' - - - - - - - - - - - - - .- - - ( M n

$'

~

..---------------(A)n
--------------------~

3'4

"fIr_aJ tlrS1 slr an;;!

primer. OSP1, to mRNA

aSP1

Copy mRNAinto eDNA
'Mtn 5',11,*",13&'4'1''''11 AT

-------"-",---_lV

__

$cc·"cc-------------~

Purity eDNA wit'h
Gi.Al.i !.M.A.X Spitl Q.utfid'!ll!!
Tail pmltied {)ONA with
$

dCW<'ItldTdT

PeR amplify tK:;~tahd cONA
IJs!tt9 tha Ablktg«i Atlohat Prim;!!t
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R@<lI"r\P;}ify prima.ry
IlsingAUAP. (X UAP.
l1i!'Stf!dGSP

Figure 5. Overview of the 5'RACE Procedure (Invitrogen).

Following isolation of total RNA, a reverse transcriptase reaction was
carried out using a trap specific primer to synthesize cDNA from the trap locus to
the 5' end of the transcript it's located on. After purification of the product, a
homopolymeric tailing reaction was completed using terminal deoxynucleotidyl
transferase (TdT) to add dC's to the 3'end of the newly synthesized cDNA. The
dC tail creates a binding site for primers necessary to amplify the cDNA product.
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Two subsequent PCR amplification reactions were carried out using primer pairs
consisting of a trap primer and an anchor primer followed by agarose gel
electrophoresis. Our analysis of the agarose gel electrophoresis of the 5'RACE
reaction shows an 850 bp product (Fig. 6). The next step in confirming the
location of the trap is to purify and
ladder

5'RACE

sequence this identified fragment.

Figure 6. PCR amplification of 5'RACE product.

Ches1 Expression in Development and Ches1 Phenotypes

To investigate possible roles and expression patterns for Che's1 in mouse
development, we used X-gal and the promoter-less

~-galactosidase-neomycin

fusion construct (Fig. 4) to determine gene expression patterns in an 11.5 days
post coitum (dpc) mating of a heterozygotic male to a wild type female (Fig. 7).
Tissues with blue staining indicate expression of

~-Galactosidase

from the gene

Figure 7. Expression analysis of Ches1 in 11.5 dpc embryos. Whole embryos were
stained with X-gal overnight to measure ~-galactosidase activity and photographed.
Panel A is a control wild type embryo obtained from a Ches1 +/- cross to a wild type
mouse. Panels Band C are stained whole mount Ches1 heterozygous embryos from the
same mating.
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trap, which is driven by the Ches1 promoter. As shown in Figures 7B and 7C,
Ches1 expression was evident in the spinal cord of the heterozygous embryos.
In phenotypic characterization of adult mice, our observations of Ches1
heterozygotes have revealed distinct skeletal abnormalities.

Analysis of Heterozygous Intercrosses
Because of unsuccessful efforts to develop a PCR that will amplify a
Ches 1-gene-trap product, we have been unable to genotypically differentiate
between Ches1 heterozygous and nullizygous mice. Consequently, we can not
definitively confirm whether the Ches1 nullizygous condition is embryonic lethal
or not. However, through analysis of heterozygous intercrosses and the resulting
offspring, the actual number of l1eterozygous/nullizygous offspring appears
conspicuously low as compared to the expected number based on a Mendelian
distribution (Table 1). This suggests embryonic lethality of the Ches1 nullizygous
condition. Furthermore, our data shows that the average number of pups per
litter of a wild type mating is between seven and eight. Based on Ches1 data
from seven heterozygous intercrosses, the average number of pups per litter is
approximately five. This further supports our conclusion that Ches1 is necessary
for embryonic development.
Table 1. Heterozygous
intercross results. Genomic
DNA samples obtained from
tail clippings were analyzed by
peR to determine their Ches1
genotype.

Results of Heterozygous Intercrosses
Wild Type

HetlNuli

Actual Number

15

21

Expected Number*

15

45

*Based on

a Mendelian

distribution
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Generation of Ches1 Deficient Cell Lines

Mouse embryonic fibroblasts (MEFs) were obtained from a timed mating
between a heterozygous male and a heterozygous female. Briefly, two 13.5 dpc
embryos were harvested from the pregnant female and disaggregated using a
syringe. The embryonic tissues were then plated onto 100 mm tissue culture
plates and passaged upon confluency. These cell lines were maintained at 37°C
using humidified air supplemented with 5% CO 2 in DMEM with 15% fetal bovine
serum and Penstrep. PCR amplification of a trap sequence using yolk sac
samples genotyped both embryos as heterozygous (or possibly nullizygous) for
Ches1. The cell line generated from the first embryo was later found to be

contaminated. The second cell line was frozen in passage two until null and wild
type cell lines are generated for comparison of cell growth kinetics.

Future Work

Further research on murine Ches1-deficient models is needed to expand
our current understanding of Ches1's role in mammalian development and the
cell cycle. To advance the data presented in this paper, we plan to examine
embryonic expression data for Ches1 at 7.5,9.5, 13.5 and 15.5 dpc. This will
allow for a more comprehensive perspective of the gene's role in development.
To confirm the presence and locus of the gene-trap in Ches1, we will proceed
with our 5'RACE analysis by sequencing the 850 bp product. Once data on the
location of the trap is obtained, a PCR to amplify a Ches1-gene-trap product will
be designed in order to differentiate between heterozygotes and nullizygotes.

Starnes 18

This PCR will allow for the retro-analysis of DNA samples from our Ches1 colony
to determine whether any nullizygous mice have been born of heterozygous
intercrosses. If the results of said genotyping support our initial deduction that
loss of Ches1 leads to embryonic lethality, we plan to determine the day and
mechanism of embryonic lethality. Additionally, we intend to generate wild type
and null cell lines in order to do cell growth kinetic experiments and cell cycle
analyses for comparisons between the three genotypes. Upon Ches1 colony
expansion, we will investigate organismal cancer susceptibility and relative life
span.
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